Search over 3,000 reports

    Imusera - API Insights, 2017

    Imusera - API Insights, 2017
    Date: Dec, 2017
    Type: Pharmaceutical Industry Report
    Pages: 30
    Geography: Global
    Delivery Timeline: 48 Hours
    SKU: DIDA0065
    DelveInsight's, Imusera - API Insights, 2017 report provides product and API manufacturers details across the globe along with the location. The report gives the clear idea on the country wise DMF filed by worldwide companies related to the Imusera. The report also highlights the patent details of Imusera.
    The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.
    Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.
    Evaluate the marketing status of Imusera to exploit opportunities for generic Imusera development opportunities
    Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details with respect to Imusera
    API intelligence over Imusera and gaining primary intelligence over Active Ingredient manufacturers by country
    Make more informed business decisions from insightful and in-depth analysis of the Imusera's performance
    Imusera Overview
    Imusera Global Sales Assessment
    Imusera Historical Global Sales
    Imusera Forecasted Global Sales
    Product Description
    Mechanism of Action
    Pharmacodynamic Properties
    Pharmacokinetic Properties
    Product Details by country
    Patent Information
    Global API Manufacturers Assessment
    Active Pharmaceutical Ingredient (API) Manufacturers by Country
    Active Pharmaceutical Ingredient (API) Manufacturers by Region
    Consulting Services
    About DelveInsight
    Table 1: Imusera Historical Global Sales from 2009-2016 (in million USD)
    Table 2: Imusera Forecasted Global Sales from 2017-2022 (in million USD)
    Table 3: Imusera General Description
    Table 4: Product Details by country
    Table 5: Patent Information
    Table6: API Manufacturers by country
    Table 7: API Manufacturers by Region
    Figure 1: Imusera Historical Global Sales from 2009-2016 (in million USD)
    Figure 2: Imusera Forecasted Global Sales from 2017-2022 (in million USD)
    Figure 3: Imusera Patent Details
    Figure 4: Imusera API Manufacturers by Country
    Figure 5: Imusera API Manufacturers by Region
    Mitsubishi Tanabe Pharma and Novartis
    Multiple Sclerosis
    Imusera Marketed Drugs Overview
    Imusera Market Assessment
    Imusera API Manufacturers/ Active Pharmaceutical Ingredients Manufacturers
    Imusera US DMF
    Imusera US Drug Master Files
    Imusera Active Substance Master File/ EUDMF
    Imusera Generic players
    Imusera Patent Expiration
    Imusera Patent Exclusivity
    Imusera API Manufacturers
    Imusera Global Forecasted Sales Figure
    • Single User License
      (20% Off)
    • Site License
      (30% Off)
    • Global License
      (40% Off)

    Contact Us

    +91-11-45689769, +91 9650213330


    New Delhi-110075, India

    Latest Tweets

    • Copyright © 2017 Delveinsight.
    • Sitemap